Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes
Conditions: Acute Biphenotypic Leukemia; Acute Lymphoblastic Leukemia in Remission; Acute Myeloid Leukemia in Remission; Blasts Under 10 Percent of Bone Marrow Nucleated Cells; Blasts Under 5 Percent of Bone Marrow Nucleated Cells; Chronic Myelogenous Leukemia, BCR-ABL1 Positive ; Cytogenetic Abnormality; High Risk Myelodysplastic Syndrome; Myelodysplastic Syndrome With Excess Blasts; Pancytopenia; Refractory Anemia Interventions: Drug: Cyclophosphamide; Drug: Fludarabine; Other: Laboratory Biomarker Analysis; Drug: Thiotepa; Radiation: Total-Body Irradiation; Biological: Umbilical Cord Blood-derived Hematopoietic CD34-positive Progenitor Cells; Procedure: Umbilical Cord Blood Transplantation Sponsors: Fred Hutchinson Cancer Research Center; National Cancer Institute (NCI); National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Acute Leukemia | Anemia | Cancer & Oncology | Cardiology | Chronic Leukemia | Chronic Myeloid Leukaemia | Heart | Heart Transplant | Leukemia | Lung Transplant | Myelodysplastic Syndrome | Pancytopenia | Research | Transplant Surgery | Transplants